Abstract
The results of using a standard combination of cytotoxic agents in 27 cases of secondary liver cancer are reported. A brief review of the methods available for treating hepatic metastases from solid tumours, as opposed to lymphomata, is included. The response rate depends on the site of the primary lesion. It is suggested that in patients with mammary or colorectal primary tumours, combination chemotherapy represents an advance in treatment with an objective response rate of 73% and 66% respectively in the 2 groups. The method requires no specialized equipment as neither grossly deranged liver enzymes nor jaundice are contra-indications to treatment, and toxicity is easily monitored and readily controlled.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Priestman, T., Hanham, I. Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy. Br J Cancer 26, 466–472 (1972). https://doi.org/10.1038/bjc.1972.64
Issue Date:
DOI: https://doi.org/10.1038/bjc.1972.64
This article is cited by
-
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
BMC Cancer (2019)
-
Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum
Diseases of the Colon & Rectum (1982)